Aflibercept in macular edema secondary to retinal vein occlusion: A real life study.

about

Aflibercept in macular edema secondary to retinal vein occlusion: A real life study.

Item

http://www.wikidata.org/entity/Q47132309

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Aflibercept in macular edema secondary to retinal vein occlusion: A real life study.

@en

Aflibercept in macular edema secondary to retinal vein occlusion: A real life study.

@nl

type

Item

label

Aflibercept in macular edema secondary to retinal vein occlusion: A real life study.

@en

Aflibercept in macular edema secondary to retinal vein occlusion: A real life study.

@nl

prefLabel

Aflibercept in macular edema secondary to retinal vein occlusion: A real life study.

@en

Aflibercept in macular edema secondary to retinal vein occlusion: A real life study.

@nl

P1476

Aflibercept in macular edema secondary to retinal vein occlusion: A real life study.

@en

P2093

Abdullah Ozkaya

http://www.w3.org/2001/XMLSchema#string

Beril Tulu

http://www.w3.org/2001/XMLSchema#string

Ruveyde Garip

http://www.w3.org/2001/XMLSchema#string

P2860

Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study

Ranibizumab versus aflibercept for macular edema due to central retinal vein occlusion: 18-month results in real-life data.

SCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion

Central retinal vein occlusion: review of management.

Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study.

Comparison between Intravitreal Triamcinolone with Grid Laser Photocoagulation versus Bevacizumab with Grid Laser Photocoagulation Combinations for Branch Retinal Vein Occlusion.

Therapies for macular edema associated with central retinal vein occlusion: a report by the American Academy of Ophthalmology.

Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion: 52-Week Results of the VIBRANT Study.

Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France

Twelve-month outcomes in patients with retinal vein occlusion treated with low-frequency intravitreal ranibizumab.

P304

211-215

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.SJOPT.2017.09.009

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29234221

http://www.w3.org/2001/XMLSchema#string

P932

5717494

http://www.w3.org/2001/XMLSchema#string